David Drutz's Net Worth

$395 Thousand

Estimate Recalculated Feb 7, 2024 03:59PM EST

Who is David Drutz?

David Drutz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Altimmune, Inc., and Midatech Pharma US Inc..

SEC CIK

David Drutz's CIK is 0001428764

Past Insider Trading and Trends

2017 was David Drutz's most active year for acquiring shares with 13 total transactions. David Drutz's most active month to acquire stocks was the month of April. 2015 was David Drutz's most active year for disposing of shares, totalling 13 transactions. David Drutz's most active month to dispose stocks was the month of November. 2012 saw David Drutz paying a total of $68,282.50 for 125,000 shares, this is the most they've acquired in one year. In 2015 David Drutz cashed out on 805,895 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Altimmune, Inc. (ALT) Snapshot price: $10.375

Investor

David Drutz owns 49,936 units of Common Stock, par value $0.0001 which is worth $518,086.00. From 2017 to 2023 David Drutz acquired a total of 50,605 shares in Altimmune, Inc. at a cost of $37,506.70.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 28
Form 4
+1.02%
300
$2.88
$862.50
29.79K
Aug 15
Form 4
+0.69%
139
$2.40
$333.60
20.15K
Nov 18
Form 4
—
0
—
—
0
Sep 29
Form 4
+5.26%
1K
$8.00
$8,000.00
20.01K
Jun 15
Form 4
+6.74%
1.2K
$4.50
$5,400.00
19.01K
May 24
Form 4/A
—
0
—
—
0
May 4
Form 4
+0.39%
70
$2.40
$168.00
17.88K
Jan 25
Form 4
+0.79%
139
$2.40
$333.60
17.81K
Dec 14
Form 4
+0.40%
70
$2.40
$168.00
17.67K
Nov 19
Form 4
—
0
—
—
0
Sep 23
Form 4
+0.34%
60
$2.40
$144.00
17.6K
Nov 13
Form 4
+2,431.46%
16.85K
—
—
17.54K
Sep 24
Form 4
—
0
—
—
0
Sep 24
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 13
Form 4
+48.13%
10K
$2.21
$22,097.00
30.78K
Aug 22 - Aug 23
Form 4
∞
20.78K
—
—
20.78K
May 4
Form 3
—
0
—
—
0
No matching records found

Midatech Pharma US Inc. No price found

Executive Chairman and CMO

David Drutz used to own units in Common Stock but no longer holds any shares there. From 2008 to 2015 David Drutz acquired a total of 149,167 shares in Midatech Pharma US Inc. at a cost of $85,722.50, David also disposed a total of 20,614 shares of Midatech Pharma US Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-20.61K
—
—
0
Dec 4
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Mar 4
Form 4
+32.02%
25K
$0.70
$17,440.00
103.07K
May 17
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Jan 18
Form 4
+47.10%
25K
$1.06
$26,500.00
78.07K
Sep 17
Form 4
+89.05%
25K
$0.77
$19,250.00
53.07K
Jun 8
Form 4
+813.54%
25K
$0.90
$22,532.50
28.07K
May 29
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Dec 27
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Mar 23
Form 4
+25.53%
10K
—
—
49.17K
Jan 4
Form 4
+11.91%
4.17K
—
—
39.17K
Jan 8
Form 4
∞
35K
—
—
35K
Apr 29
Form 3
—
0
—
—
0
No matching records found